Skip to main content

Currently Skimming:

References
Pages 201-216

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 201...
... . AMA policy on drug formularies and therapeutic interchange in inpatient and ambulatory patient care settings.
From page 202...
... Predicting formulary decisions in health maintenance organizations involving nonsteroidal anti-inflammatory drugs.
From page 203...
... Medicaid policies for HIV-related prescription drugs. Health Care Financing Rev.
From page 204...
... Pharmacy Benefits Management: A Valuable Product Line. Washington, DC: Department of Veterans Affairs; 1989.
From page 205...
... Medicaid drug formulary restrictions.
From page 206...
... Pharmacy benefits in health maintenance organizations. Health Affairs.
From page 207...
... State Medicaid officials battle drug firms in war to cut costs. Hospitals.
From page 208...
... The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
From page 209...
... The effects of an internal analgesic formulary restriction on Medicaid drug expenditures in Wisconsin. Medical Care.
From page 210...
... Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical Approach. The American Journal of Managed Care.
From page 211...
... Newman R Drug formulary restrictions as a cost-containment policy in medicaid programs.
From page 212...
... Washington, DC: Pharmaccutical Manufacturers Association; 1993. Pharmacy Benefits Management in a Valuable Product Line.
From page 213...
... A public policy strategy for drug formularies: preparation or procrastination necessity for implementing an effective national formulary.
From page 214...
... Managed Care Pharmacy Practice. Gaithersburg, MD: Aspen Publishers, Inc.; 1999.
From page 215...
... Selective contracting and patient outcomes: A case study of formulary restrictions for selective serotonin reuptake inhibitor antidepressants.
From page 216...
... Does therapeutic interchange hurt patients?


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.